GlassScriptPhysician profile
Tzu Lu Lin
NPI 1710502414
$1,350.92
in general payments reported to CMS, 2019-2025
9 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.37 · 2023: $227 · 2024: $382 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,326.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $718.67 | 2023-2025 | Grafix Pl, Stravix Pl, Oasis |
| Linvatec Corporation | $226.05 | 2025 | Biobrace 23mm, Colink Plating System, Allograft Tissue |
| Treace Medical Concepts, INC. | $110.78 | 2024-2025 | |
| Orthofix Medical, INC. | $92.72 | 2023 | Spinal-Stim, Physio-Stim |
| Cornerstone Medical Associates, INC. | $78.98 | 2023-2024 | |
| Mimedx Group, INC. | $45.30 | 2025 | |
| Urgo Medical North America, LLC | $36.30 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Melinta Therapeutics, LLC | $24.37 | 2021 | |
| Medtronic, INC. | $17.75 | 2025 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tzu Lu Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.